PYC Therapeutics Ltd
F:PH7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PYC Therapeutics Ltd
F:PH7
|
AU |
Dividends
Dividend Yield
PYC Therapeutics Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
PYC Therapeutics Ltd
PH7 have decreased by 0%.
Payout Ratio
PYC Therapeutics Ltd
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
PH7 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
PH7 Price
PYC Therapeutics Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -43% |
| Market Capitalization | 1.3B EUR |
| Shares Outstanding | 4 471 980 000 |
| Percentage of Shares Shorted |
N/A
|
PH7 Return Decomposition
Main factors of price return
Stock Splits
PH7's latest stock split occurred on Oct 22, 2020
The company executed a 407-for-404 stock split, meaning that for every 404 shares held, investors received 407 new shares.
Before the split, PH7 traded at 0.108 per share. Afterward, the share price was about 0.102.
The adjusted shares began trading on Oct 22, 2020. This was stock split number 3 in PH7's history, following the previous one in Nov 4, 2019.